Pacira BioSciences, Inc. (PCRX) › Shares OutstandingPacira BioSciences, Inc. (PCRX) — Shares OutstandingAnnual figures by period end, from SEC filings.2010-12-31: 574.0K2011-12-31: 25.34M2012-12-31: 32.62M2013-12-31: 33.64M2014-12-31: 36.15M2015-12-31: 36.85M2016-12-31: 37.48M2017-12-31: 40.67M2018-12-31: 41.22M2019-12-31: 41.91M2020-12-31: 43.64M2021-12-31: 44.73M2022-12-31: 45.93M2023-12-31: 46.48M2024-12-31: 46.24M2025-12-31: 41.12M41.12M2010-12-31Shares Outstanding (shares)2025-12-31Period endedShares OutstandingChange YoYSource filing2025-12-3141.12M-11.1%2026-02-26Balance as of period end2024-12-3146.24M-0.5%2026-02-26Balance as of period end2023-12-3146.48M+1.2%2025-02-27Balance as of period end2022-12-3145.93M+2.7%2024-02-29Balance as of period end2021-12-3144.73M+2.5%2023-02-28Balance as of period end2020-12-3143.64M+4.1%2022-02-28Balance as of period end2019-12-3141.91M+1.7%2021-03-01Balance as of period end2018-12-3141.22M+1.4%2020-02-21Balance as of period end2017-12-3140.67M+8.5%2019-02-28Balance as of period end2016-12-3137.48M+1.7%2018-02-28Balance as of period end2015-12-3136.85M+1.9%2017-03-01Balance as of period end2014-12-3136.15M+7.5%2016-02-25Balance as of period end2013-12-3133.64M+3.1%2015-02-24Balance as of period end2012-12-3132.62M+28.7%2014-02-25Balance as of period end2011-12-3125.34M+4314.2%2013-03-07Balance as of period end2010-12-31574.0K—2012-03-27Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per ShareWeighted Average Diluted SharesEPS (Basic)